Table 1.
Characteristics of the respondents
| Variable | Kampala (urban) [n = 456 (58%)] | Iganga/Mayuge (rural) [n = 326 (42%)] | Total [N = 782] |
|---|---|---|---|
| Age, years [median (minimum–maximum)] | 25 (1–78) | 17 (1–73) | 22 (1–78) |
| Age groups, years | |||
| 0–4 | 49 (38.0) | 80 (62.0) | 129 |
| 5–10 | 64 (56.6) | 49 (43.4) | 113 |
| 11–18 | 29 (35.4) | 53 (64.6) | 82 |
| 19–29 | 145 (63.9) | 82 (36.1) | 227 |
| 30–39 | 97 (73.5) | 35 (26.5) | 132 |
| ≥ 40 | 72 (72.7) | 27 (27.3) | 99 |
| Sex | |||
| Male | 223 (68.8) | 101 (31.2) | 324 |
| Female | 233 (50.8) | 225 (49.1) | 458 |
| Pregnant women | 9 (36.0) | 16 (64.0) | 25 |
| First trimester | 4 (50.0) | 4 (50.0) | 8 |
| Second trimester | 3 (33.3) | 6 (66.7) | 9 |
| Third trimester | 2 (25.0) | 6 (75.0) | 8 |
| Facility ownership | |||
| Private | 23 (100.0) | 0 (0.0) | 23 |
| Public | 433 (57.0) | 326 (43.0) | 759 |
| Malaria diagnostic test performed | 272 (45.6) | 325 (54.4) | 597 |
| Test results | |||
| Negative | 40 (97.6) | 1 (2.4) | 41 |
| Positive | 232 (41.7) | 324 (58.3) | 556 |
| Not performed | 184 (99.5) | 1 (0.5) | 185 |
| Antimalarial drugs | |||
| First-line ACTs | 441 (58.0) | 320 (42.0) | 761 |
| Other antimalarial | 15 (71.4) | 6 (28.6) | 21 |
| Presence of comorbidities | 216 (64.7) | 118 (35.3) | 334 |
| HIV/AIDS | 72 (60.5) | 47 (39.5) | 119 |
| Tuberculosis | 79 (75.2) | 26 (24.8) | 105 |
| Peptic ulcers | 45 (62.5) | 27 (37.5) | 72 |
| Asthma | 19 (82.6) | 4 (17.4) | 23 |
| Hypertension | 1 (6.7) | 14 (93.3) | 15 |
The data in parentheses, apart from the first line are percentages
ACT artemisinin-based combination therapies